Patents Assigned to DEERLAND ENZYMES, INC.
  • Patent number: 12194142
    Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.
    Type: Grant
    Filed: June 21, 2021
    Date of Patent: January 14, 2025
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20240325465
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Application
    Filed: June 6, 2024
    Publication date: October 3, 2024
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Patent number: 12005087
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: June 11, 2024
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20240075078
    Abstract: Methods of using Bacillus subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 7, 2024
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Patent number: 11813296
    Abstract: Methods of using Bacillus subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: November 14, 2023
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20230116978
    Abstract: This disclosure relates to an enzymatic method including the steps of adding water to a reactor vessel with gentle mixing and minimal heating, adding osmotic protectant solution, adding plant material to the reactor, adding cell wall degrading enzymes at 0.1% wt/wt based on plant weight, heating the reactor now filled with plant material, osmotic protectant solution and enzyme blend solution to 30° C.-35° C., adding the enzyme mixture to the reactor and starting the timer for up to 2 hours, adding bulk density enhancer, further mixing the product, and drying the finished product containing protoplasts. The protoplast containing product may be provided in a dietary supplement for human use having antioxidant and anti-inflammatory properties.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 20, 2023
    Applicant: Deerland Enzymes, Inc.
    Inventor: John Deaton
  • Patent number: 11160838
    Abstract: Methods of treating, removing, or preventing the accumulation of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, with compositions containing Bacillus subtilis or material secreted from Bacillus subtilis are provided. Compositions including Bacillus subitlis or material secreted from Bacillus subtilis that can be used in methods of treating, removing, or preventing the accumulation, growth, or activity of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, are provided.
    Type: Grant
    Filed: August 10, 2020
    Date of Patent: November 2, 2021
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20210315808
    Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 14, 2021
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20210315945
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Application
    Filed: June 22, 2021
    Publication date: October 14, 2021
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20210145899
    Abstract: Methods of treating, removing, or preventing the accumulation of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, with compositions containing Bacillus subtilis or material secreted from Bacillus subtilis are provided. Compositions including Bacillus subitlis or material secreted from Bacillus subtilis that can be used in methods of treating, removing, or preventing the accumulation, growth, or activity of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, are provided.
    Type: Application
    Filed: August 10, 2020
    Publication date: May 20, 2021
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20200108106
    Abstract: Methods of using Bacillus Subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus Subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 9, 2020
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20190255122
    Abstract: This disclosure provides a method of treating gastrointestinal inflammation such as inflammatory bowel disease (IBS) with a bacteriophage containing composition. The bacteriophage containing composition can be used as prebiotic supplementation and support of the gastrointestinal microflora. This disclosure relates to compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.
    Type: Application
    Filed: September 25, 2018
    Publication date: August 22, 2019
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20190125810
    Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.
    Type: Application
    Filed: September 25, 2018
    Publication date: May 2, 2019
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20190125811
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Application
    Filed: September 25, 2018
    Publication date: May 2, 2019
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Patent number: 9839657
    Abstract: Disclosed herein are compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: December 12, 2017
    Assignee: DEERLAND ENZYMES, INC.
    Inventors: John Deaton, Elizabeth Ertle, Hilton Grant Dawson
  • Publication number: 20130101634
    Abstract: An antimicrobial composition for reducing bacterial overgrowth in the small intestine is disclosed. The composition comprises a lytic enzyme combined with one or more anti-microbial essential oils, and a probiotic. Unlike broad spectrum antibiotics the disclosed composition does not enter the blood stream, does not destroy all intestinal microflora, and can be used on a continuing basis.
    Type: Application
    Filed: October 12, 2012
    Publication date: April 25, 2013
    Applicant: DEERLAND ENZYMES, INC.
    Inventor: Deerland Enzymes, Inc.